Previous close | 0.8000 |
Open | 0.8000 |
Bid | 0.0500 |
Ask | 2.5500 |
Strike | 115.00 |
Expiry date | 2024-12-20 |
Day's range | 0.8000 - 0.8000 |
Contract range | N/A |
Volume | |
Open interest | 140 |
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
Haemonetics (HAE) Q4 revenues were driven by an uptick in the Plasma and Hospital segments.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.